← Back
Data updated: Mar 10, 2026
MC2
Immunology
MC2 is a pharmaceutical company focused on Immunology. Key products include WYNZORA.
2020
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs Phase 3: 2 Phase 2: 2
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-07-20
- Latest
- 2020-07-20
- Applications
- 1